BRPI0811985A2 - Complexos de ferro-derivado de carboidrato solúveis em água, produção dos mesmos e medicamentos que contêm os mesmos - Google Patents

Complexos de ferro-derivado de carboidrato solúveis em água, produção dos mesmos e medicamentos que contêm os mesmos

Info

Publication number
BRPI0811985A2
BRPI0811985A2 BRPI0811985-6A2A BRPI0811985A BRPI0811985A2 BR PI0811985 A2 BRPI0811985 A2 BR PI0811985A2 BR PI0811985 A BRPI0811985 A BR PI0811985A BR PI0811985 A2 BRPI0811985 A2 BR PI0811985A2
Authority
BR
Brazil
Prior art keywords
same
iron
production
water soluble
products containing
Prior art date
Application number
BRPI0811985-6A2A
Other languages
English (en)
Inventor
Stefan Reim
Erik Philipp
Felix Funk
Hans-Martin Mueller
Peter Geisser
Original Assignee
Vifor Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38287550&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0811985(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vifor Int Ag filed Critical Vifor Int Ag
Publication of BRPI0811985A2 publication Critical patent/BRPI0811985A2/pt
Publication of BRPI0811985B1 publication Critical patent/BRPI0811985B1/pt
Publication of BRPI0811985B8 publication Critical patent/BRPI0811985B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/18—Oxidised starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/18—Oxidised starch
    • C08B31/185—Derivatives of oxidised starch, e.g. crosslinked oxidised starch

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0811985A 2007-05-29 2008-05-21 complexos de ferro-derivado de carboidrato solúveis em água, seus usos e seu processo de preparação, e medicamentos BRPI0811985B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07109081A EP1997833A1 (de) 2007-05-29 2007-05-29 Wasserlösliche Eisen-Kohlenhydratderivat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
PCT/EP2008/056276 WO2008145586A1 (de) 2007-05-29 2008-05-21 Wasserlösliche eisen-kohlenhydratderivat-komplexe, deren herstellung und diese enthaltende arzneimittel

Publications (3)

Publication Number Publication Date
BRPI0811985A2 true BRPI0811985A2 (pt) 2014-11-18
BRPI0811985B1 BRPI0811985B1 (pt) 2020-04-07
BRPI0811985B8 BRPI0811985B8 (pt) 2021-05-25

Family

ID=38287550

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811985A BRPI0811985B8 (pt) 2007-05-29 2008-05-21 complexos de ferro-derivado de carboidrato solúveis em água, seus usos e seu processo de preparação, e medicamentos

Country Status (26)

Country Link
US (1) US8263577B2 (pt)
EP (2) EP1997833A1 (pt)
JP (1) JP5259700B2 (pt)
KR (1) KR101168085B1 (pt)
CN (1) CN101679530B (pt)
AR (1) AR065997A1 (pt)
AU (1) AU2008257683B2 (pt)
BR (1) BRPI0811985B8 (pt)
CA (1) CA2682587C (pt)
CL (1) CL2008001549A1 (pt)
CO (1) CO6241161A2 (pt)
ES (1) ES2547304T3 (pt)
GT (1) GT200900308A (pt)
IL (1) IL201294A (pt)
MA (1) MA31456B1 (pt)
MX (1) MX2009012889A (pt)
MY (1) MY158004A (pt)
NZ (1) NZ581487A (pt)
PE (1) PE20090317A1 (pt)
PL (1) PL2148890T3 (pt)
PT (1) PT2148890E (pt)
RU (1) RU2441881C2 (pt)
TN (1) TN2009000443A1 (pt)
TW (1) TWI372621B (pt)
WO (1) WO2008145586A1 (pt)
ZA (1) ZA200907672B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10249552A1 (de) * 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
PT1973549T (pt) 2006-01-06 2016-10-25 Luitpold Pharm Inc Métodos e composições para administração de ferro
LT3156075T (lt) 2009-03-25 2021-01-11 Pharmacosmos Holding A/S Oligosacharidas ir jo paruošimo būdas
EP2496595A2 (en) * 2009-11-04 2012-09-12 Symed Labs Limited Process for the preparation of iron (iii) carboxymaltose complex
US9394324B2 (en) 2010-03-23 2016-07-19 Vifor (International) Ag Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
CN101891832B (zh) * 2010-07-22 2012-01-04 山东农业大学 一种无碱均相生产氧化淀粉方法
WO2012104204A1 (en) 2011-01-31 2012-08-09 Vifor (International) Ag Iron-carbohydrate complex compounds for the intravenous therapy of malaria
CA2849926C (en) * 2011-10-13 2020-07-21 Vidasym, Inc. Iron-fiber composition, preparation and uses thereof
WO2014138016A1 (en) 2013-03-08 2014-09-12 Vidasym, Inc. Metal ion-functional fiber component complex compositions, preparation and uses thereof
US9370202B2 (en) 2013-03-15 2016-06-21 LG Bionano, LLC Encapsulated metal ion nanoclusters
CN107438626A (zh) * 2015-03-23 2017-12-05 苏文生命科学有限公司 水溶性三价铁碳水化合物复合物的制备
CN105125577B (zh) * 2015-07-29 2018-05-18 南京生命能科技开发有限公司 一种稳定的糖-铁复合物及其制备方法
CN105520955B (zh) * 2015-12-21 2018-05-11 南京生命能科技开发有限公司 一种羧基麦芽糖铁药用组合物及其制备方法
US20210155651A1 (en) * 2018-04-05 2021-05-27 Msn Laboratories Private Limited, R&D Center Process for the preparation of iron (iii) carboxymaltose
CN115368477B (zh) * 2021-05-21 2023-05-02 武汉科福新药有限责任公司 高得率、高含铁量的羧基麦芽糖铁的制备方法
CN115368478B (zh) * 2021-05-21 2023-07-04 武汉科福新药有限责任公司 一种羧基麦芽糖铁的制备方法
CN115322265A (zh) * 2022-08-29 2022-11-11 滨州学院 一种羧基麦芽糖控制性氧化与纯化工艺
WO2026017897A1 (en) 2024-07-18 2026-01-22 Malian Biologicals Gmbh Iron supplementation in affective disorders and/or post-traumatic stress disorder (ptsd) and/or serotonin-dependent diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK172860B1 (da) * 1998-03-25 1999-08-16 Pharmacosmos Holding As Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
DE10249552A1 (de) * 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US7964568B2 (en) * 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
ITMO20050056A1 (it) * 2005-03-15 2006-09-16 Biofer Spa Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi.
EP1757299A1 (de) * 2005-08-25 2007-02-28 Vifor (International) Ag Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung

Also Published As

Publication number Publication date
ES2547304T3 (es) 2015-10-05
JP5259700B2 (ja) 2013-08-07
TWI372621B (en) 2012-09-21
WO2008145586A1 (de) 2008-12-04
AU2008257683B2 (en) 2012-06-21
BRPI0811985B8 (pt) 2021-05-25
CN101679530B (zh) 2012-07-04
NZ581487A (en) 2012-04-27
EP2148890A1 (de) 2010-02-03
JP2010528166A (ja) 2010-08-19
GT200900308A (es) 2011-09-06
KR20100010502A (ko) 2010-02-01
RU2009149175A (ru) 2011-07-10
BRPI0811985B1 (pt) 2020-04-07
ZA200907672B (en) 2010-07-28
IL201294A0 (en) 2010-05-31
CA2682587C (en) 2013-05-14
MX2009012889A (es) 2009-12-10
MY158004A (en) 2016-08-30
RU2441881C2 (ru) 2012-02-10
EP2148890B1 (de) 2015-08-19
US8263577B2 (en) 2012-09-11
IL201294A (en) 2013-06-27
EP1997833A1 (de) 2008-12-03
CO6241161A2 (es) 2011-01-20
CA2682587A1 (en) 2008-12-04
PT2148890E (pt) 2015-10-15
PL2148890T3 (pl) 2016-01-29
CN101679530A (zh) 2010-03-24
PE20090317A1 (es) 2009-04-24
TW200900055A (en) 2009-01-01
CL2008001549A1 (es) 2009-09-25
US20100305063A1 (en) 2010-12-02
MA31456B1 (fr) 2010-06-01
HK1140219A1 (en) 2010-10-08
AR065997A1 (es) 2009-07-15
TN2009000443A1 (en) 2011-03-31
KR101168085B1 (ko) 2012-07-24
AU2008257683A1 (en) 2008-12-04

Similar Documents

Publication Publication Date Title
BRPI0811985A2 (pt) Complexos de ferro-derivado de carboidrato solúveis em água, produção dos mesmos e medicamentos que contêm os mesmos
EP2401264A4 (en) PEPTOID OLIGOMERS, PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THEIR USE
BRPI0806941A2 (pt) Implementos de higiene bucal que têm elementos flexíveis, e métodos de produção dos mesmos
EP2101745A4 (en) ADMINISTRATION OF MEDICINES
PT2590976E (pt) Derivados da imidazopiridina, seu processo de preparação e sua utilização terapêutica
BRPI0813011A2 (pt) Formulação injetável aquosa estéril, processo de preparação da mesma e sua utilização
DK2151438T3 (da) Lægemiddel indeholdende PPAR-Deltaagonist
BRPI1009481A2 (pt) compostos de 2-acetamido-5-aril-1,2,4-triazolonas substituídas, seu processo de preparação, seu uso e medicamento compreendendo os mesmos
EP1933936A4 (en) IMPREGNATED ENVELOPE OF MEDICAMENT
BR112013015592A2 (pt) dericados de biciclo-[3.2.1]-octilamida e usos dos mesmos
BRPI0809667A2 (pt) Composto, medicamento e composição farmacêutica que o contém e uso do composto
HRP20181598T1 (hr) Uporaba i pripravci za liječenje hidradenitis suppurativa (hs)
HUE061596T2 (hu) Szubsztituált dimer kinazolin származék, annak elõállítása és alkalmazása az I. és II. típusú cukorbetegség kezelésére szolgáló gyógyszerkészítményekben
EP2506835A4 (en) COMPRESSIBLE COATED PHARMACEUTICAL COMPOSITION, TABLETS AND MANUFACTURING METHOD THEREFOR
BR112012006404A2 (pt) derivados de di-hidropteridinona, processo de preparação e uso farmacêutico dos mesmos
FR2967677B1 (fr) Derives de polysaccharides comprenant un motif alcene et reaction de couplage par chimie thio-clic
ATE538652T1 (de) Synergistische pharmazeutische kombination für die behandlung von krebs
CL2008001323A1 (es) Compuestos derivados de triazolil aminopiridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
BRPI0715342A2 (pt) Derivados de 6-carboxi-normorfinano, síntese e usos dos mesmos
EP2508257A4 (en) VIRUIDE AND FUNCTIONAL VIRCIDATE PRODUCT THEREWITH
BR112014008224A2 (pt) derivados do fator vii e viia de coagulação sanguínea, conjugados e complexos que incluem o mesmo e utilização do mesmo
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
EP2213326A4 (en) MEDICAL ULTRASONIC PASTE
BRPI0915527A2 (pt) pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos
BR112013010709A2 (pt) derivado de ácido trans-2-decenoico e agente farmacêutico contendo o mesmo

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 07/04/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/05/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2776 DE 19-03-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.